FP10 High cost drugs and high risk drugs prescribing report refresh

This report has been updated to include all high cost drugs excluded from the 2019/20 National Tariff and new cytotoxic and other high risk drugs that may not be appropriate for GP prescribing on FP10.

It may be a good time to revisit your data to identify any inappropriate prescribing that you may wish to investigate.

View >>